Role of Long Acting Injectable Medications in the Management and Prevention of HIV
Role of Long-Acting Injectable Medications in the Management and Prevention of HIV
Schedule:
November 19, 2021, 1:30 pm to 2:30 pm, Dartmouth-Hitchcock Medical Center, Lebanon, NH
Audience:
Accredited for Pharmacists
Other interested health care professionals welcome
Credits:
1 Contact Hour knowledge based
0.1CEU will be awarded under the provider
0837-9999-21-235-L01-P
Presenter:
Frances Murray, BS, PharmD, RPh
PGY1 Pharmacy Resident, Dartmouth Hitchcock
Registration:
Free to all attendees
Learning Objectives:
After attending this program, participants will be able to:
- Review current guideline recommendations regarding the management of HIV and the future role of long-acting cabotegravir/rilpivirine infection within these guidelines
- Explain which patient populations are candidates for cabotegravir/rilpivirine long- acting injectable
- Describe the future role of cabotegravir long-acting injectable for PrEP
Requirements for Receiving CE Credit:
- Successful completion of post-presentation questions
- Participation at live program
- Complete program evaluation form